Bcal Diagnostics Limited (ASX: BDX)
Sector: Health Care
Market cap: A$31M (as of 2 Nov 2026)
BCAL Diagnostics Limited is a biotechnology company developing a blood based diagnostic test for breast cancer.
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 1 Oct 2026 | Capital Property Corporation Pty Ltd as trustee for Carrington Trust, Brindabella Southern Pty Limited as trustee for Brindabella Southern Trust | Increase | 14.57% → 15.57% | Filing ↗ |
| 29 Aug 2025 | CAPITAL PROPERTY CORPORATION PTY LTD | Entry | ?% → 11.74% | Filing ↗ |
| 30 Aug 2024 | CAPITAL PROPERTY CORPORATION PTY LTD <CARRINGTON A/C> | Entry | ?% → 9.31% | Filing ↗ |
| 21 June 2024 | Capital Property Corporation Pty Ltd as trustee for Carrington Trust, Brindabella Southern Pty Limited as trustee for Brindabella Southern Trust | Increase | 6.400% → 7.540% | Filing ↗ |
| 1 May 2024 | Capital Property Corporation Pty Ltd as trustee for Carrington Trust, Brindabella Southern Pty Limited as trustee for Brindabella Southern Trust | Increase | 6.4% → 16.193425% | Filing ↗ |
Director trades — on-market
Cash and runway
Ask about BDX in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has BDX raised money in the last year, and at what discount?
- What was BDX's latest cash position and runway?
Loading BDX…